CS Must Follow up Key Issues for Advocacy as Identified Via Tendai Project
Daniel Molokele
I am writing to let you know SARPAM recently got some feedback from DFID in terms of the TENDAI score cards reports that were done after the March monitors submission
DFID would like some further analysis on the following aspects:
1. It is not enough for the CS to just report the stock-out statistics and not do something further such as to explain why there is such a problem.
2. If there is an emerging trend of an issue affecting access to medicines both at a country or community level, the CS must clearly identify it
3. Once the CS has identified the issue, they must seek to investigate why it is so?
4. Specific follow up questions must be asked by the monitors at a specific clinic and the answers submitted using the advocacy form
5. National Co-ordinators and CAF partners must also have follow up questions at a district, provincial or national level
6. Once the investigation/inquiry is completed, the CS must engage the relevant authorities for an urgent solution till the issue affecting access to medicines is fully resolved.
7. National Co-ordinators must compile progress reports for the CAF and SARPAM on all the identified issues that need to be resolved in order to improve access to medicines
Mr. Daniel Molokele
Civil Society Partnerships Co-ordinator
SARPAM
Southern Africa Regional Programme on Access to Medicines and Diagnostics
This message is intended for the addressee only. Information and attachments in this e-mail may contain confidential, proprietary, or legally privileged information. If you are not the intended recipient, or responsible for delivery of the message to the intended recipient, any disclosure, copying, distribution, or any action taken is prohibited and may be unlawful, and could result in a claim against you. Please consider the environment before printing this e-mail.